A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer's Disease.

Amir Abbas Tahami MonfaredAli TafazzoliWeicheng YeAmeya ChavanKristen A DegerQuanwu Zhang

Published in: Neurology and therapy (2022)

This analysis demonstrated that DMTs that provide even small delays in the onset of AD can lead to an increase in disease-free years and sizable savings in the cost of care, providing significant benefits to patients, caregivers, and society.

Keyphrases

end stage renal disease
palliative care
ejection fraction
healthcare
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
risk factors
climate change
patient reported
health insurance